Options
Requirement of the RNA-editing Enzyme ADAR2 for Normal Physiology in Mice
ISSN
0021-9258
Date Issued
2011
Author(s)
Horsch, Marion
Seeburg, Peter H.
Adler, Thure
Aguilar-Pimentel, Juan Antonio
Becker, Lore
Calzada-Wack, Julia
Garrett, Lilian
Hans, Wolfgang
Higuchi, Miyoko
Hoelter, Sabine M.
Naton, Beatrix
Prehn, Cornelia
Puk, Oliver
Racz, Ildiko
Rathkolb, Birgit
Rozman, Jan
Schrewe, Anja
Adamski, Jerzy
Busch, Dirk H.
Esposito, Irene
Graw, Jochen
Ivandic, Boris
Klingenspor, Martin
Klopstock, Thomas
Mempel, Martin
Ollert, Markus W.
Schulz, Holger
Wolf, Eckhard
Wurst, Wolfgang
Zimmer, Andreas
Gailus-Durner, Valerie
Fuchs, Helmut
de Angelis, Martin Hrabe
Beckers, Johannes
DOI
10.1074/jbc.M110.200881
Abstract
ADAR2, an RNA editing enzyme that converts specific adenosines to inosines in certain pre-mRNAs, often leading to amino acid substitutions in the encoded proteins, is mainly expressed in brain. Of all ADAR2-mediated edits, a single one in the pre-mRNA of the AMPA receptor subunit GluA2 is essential for survival. Hence, early postnatal death of mice lacking ADAR2 is averted when the critical edit is engineered into both GluA2 encoding Gria2 alleles. Adar2(-/-)/Gria2(R/R) mice display normal appearance and life span, but the general phenotypic effects of global lack of ADAR2 have remained unexplored. Here we have employed the Adar2(-/-)/Gria2(R/R) mouse line, and Gria2(R/R) mice as controls, to study the phenotypic consequences of loss of all ADAR2-mediated edits except the critical one in GluA2. Our extended phenotypic analysis covering similar to 320 parameters identified significant changes related to absence of ADAR2 in behavior, hearing ability, allergy parameters and transcript profiles of brain.